Prime boost vaccines power up in people. [Nat Med. 2003] - PubMed

Related citations

Review Progress in DNA-based heterologous prime-boost immunization strategies for malaria. [Immunol Rev. 2004]
Review Progress in DNA-based heterologous prime-boost immunization strategies for malaria.
Moore AC, Hill AV. Immunol Rev. 2004 Jun; 199:126-43.
Enhanced T cell-mediated protection against malaria in human challenges by using the recombinant poxviruses FP9 and modified vaccinia virus Ankara. [Proc Natl Acad Sci U S A. 2005]
Enhanced T cell-mediated protection against malaria in human challenges by using the recombinant poxviruses FP9 and modified vaccinia virus Ankara.
Webster DP, Dunachie S, Vuola JM, Berthoud T, Keating S, Laidlaw SM, McConkey SJ, Poulton I, Andrews L, Andersen RF, et al. Proc Natl Acad Sci U S A. 2005 Mar 29; 102(13):4836-41. Epub 2005 Mar 21.
Phase 1 evaluation of 3 highly immunogenic prime-boost regimens, including a 12-month reboosting vaccination, for malaria vaccination in Gambian men. [J Infect Dis. 2004]
Phase 1 evaluation of 3 highly immunogenic prime-boost regimens, including a 12-month reboosting vaccination, for malaria vaccination in Gambian men.
Moorthy VS, Imoukhuede EB, Keating S, Pinder M, Webster D, Skinner MA, Gilbert SC, Walraven G, Hill AV. J Infect Dis. 2004 Jun 15; 189(12):2213-9. Epub 2004 May 24.
Immune responses in mice induced by prime-boost schemes of the Plasmodium falciparum apical membrane antigen 1 (PfAMA1)-based DNA, protein and recombinant modified vaccinia Ankara vaccines. [Vaccine. 2006]
Immune responses in mice induced by prime-boost schemes of the Plasmodium falciparum apical membrane antigen 1 (PfAMA1)-based DNA, protein and recombinant modified vaccinia Ankara vaccines.
Miao J, Li X, Liu Z, Xue C, Bujard H, Cui L. Vaccine. 2006 Sep 11; 24(37-39):6187-98. Epub 2006 Jun 12.
Review Clinical experience with plasmid DNA- and modified vaccinia virus Ankara-vectored human immunodeficiency virus type 1 clade A vaccine focusing on T-cell induction. [J Gen Virol. 2007]
Review Clinical experience with plasmid DNA- and modified vaccinia virus Ankara-vectored human immunodeficiency virus type 1 clade A vaccine focusing on T-cell induction.
Hanke T, Goonetilleke N, McMichael AJ, Dorrell L. J Gen Virol. 2007 Jan; 88(Pt 1):1-12.

See reviews... See all...

Cited by 5 PubMed Central articles

Interactions between human immunodeficiency virus type 1 and vaccinia virus in human lymphoid tissue ex vivo. [J Virol. 2007]
Interactions between human immunodeficiency virus type 1 and vaccinia virus in human lymphoid tissue ex vivo.
Vanpouille C, Biancotto A, Lisco A, Brichacek B. J Virol. 2007 Nov; 81(22):12458-64. Epub 2007 Sep 5.
Prime-boost vaccination with plasmid and adenovirus gene vaccines control HER2/neu+ metastatic breast cancer in mice. [Breast Cancer Res. 2005]
Prime-boost vaccination with plasmid and adenovirus gene vaccines control HER2/neu+ metastatic breast cancer in mice.
Wang X, Wang JP, Rao XM, Price JE, Zhou HS, Lachman LB. Breast Cancer Res. 2005; 7(5):R580-8. Epub 2005 May 23.
Vaccinia virus tropism for primary hematolymphoid cells is determined by restricted expression of a unique virus receptor. [J Virol. 2005]
Vaccinia virus tropism for primary hematolymphoid cells is determined by restricted expression of a unique virus receptor.
Chahroudi A, Chavan R, Kozyr N, Waller EK, Silvestri G, Feinberg MB. J Virol. 2005 Aug; 79(16):10397-407.

See all...

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

Prime boost vaccines power up in people.
Prime boost vaccines power up in people.
Nat Med. 2003 Jun ;9(6):642-3.

PubMed
Cellular immune responses induced in cattle by heterologous prime-boost vaccinat...
Cellular immune responses induced in cattle by heterologous prime-boost vaccination using recombinant viruses and bacille Calmette-Guérin.
Immunology. 2004 Jul ;112(3):461-70.

PubMed
Durable human memory T cells quantifiable by cultured enzyme-linked immunospot a...
Durable human memory T cells quantifiable by cultured enzyme-linked immunospot assays are induced by heterologous prime boost immunization and correlate with protection against malaria.
J Immunol. 2005 Nov 1 ;175(9):5675-80.

PubMed
Synergistic DNA-MVA prime-boost vaccination regimes for malaria and tuberculosis...
Synergistic DNA-MVA prime-boost vaccination regimes for malaria and tuberculosis.
Vaccine. 2006 May 22 ;24(21):4554-61. Epub 2005 Aug 24 .

PubMed
Enhanced immunogenicity of CD4(+) t-cell responses and protective efficacy of a ...
Enhanced immunogenicity of CD4(+) t-cell responses and protective efficacy of a DNA-modified vaccinia virus Ankara prime-boost vaccination regimen for murine tuberculosis.
Infect Immun. 2001 Feb ;69(2):681-6.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Display Settings:

Send to:

Prime boost vaccines power up in people.

Comment on

Publication Types, MeSH Terms, Substances

Publication Types

MeSH Terms

Substances

LinkOut - more resources

Full Text Sources

Other Literature Sources

Supplemental Content

Related citations

Cited by 5 PubMed Central articles

Related information

Recent activity

Simple NCBI Directory

Getting Started

Resources

Popular

Featured

NCBI Information